Loading...
MVC logo

Metrovacesa S.A.BME:MVC Stock Report

Market Cap €1.6b
Share Price
€10.30
My Fair Value
€9.81
5.0% overvalued intrinsic discount
1Y20.5%
7D0%
Portfolio Value
​
View

Metrovacesa S.A.

BME:MVC Stock Report

Market Cap: €1.6b

Metrovacesa (MVC) Stock Overview

Operates as a real estate development company in Spain. More details

MVC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends2/6

Rewards

Trading at 12.5% below our estimate of its fair value

Earnings are forecast to grow 46.96% per year

Risk Analysis

No risks detected for MVC from our risk checks.

MVC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

MVC logo
Metrovacesa

Urban Influx And ESG Excellence Will Fuel Spain's Residential Expansion

Key Takeaways Structural supply-demand imbalances and urbanization trends drive robust sales growth, higher margins, and price appreciation in key markets. Leadership in sustainability and diversified residential formats position the company for reduced regulatory risk and stable, long-term revenue expansion.
View narrative
€9.81
FV
5.0% overvalued intrinsic discount
9.71%
Revenue growth p.a.
0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
MVC logo
Metrovacesa

Urbanization And Green Building Will Drive Lasting Value

Key Takeaways Flexible sales strategy, sustainability focus, and proptech integration position Metrovacesa for margin expansion, premium pricing, and improved operational efficiency. Strategic land assets and entry into rental and flexible living segments enable diversified, resilient income and greater institutional investment attraction.
View narrative
€11.8
FV
12.7% undervalued intrinsic discount
12.54%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
MVC logo
Metrovacesa

Soaring House Prices Will Shrink Margins Amid Mounting Compliance Costs

Key Takeaways Rapidly rising house prices and limited geographic reach heighten risks to sales, revenue, and margin growth amid growing affordability concerns and potential market shifts. Stricter regulations, higher compliance costs, and reliance on non-core land sales threaten future profitability, asset values, and reliability of cash flow.
View narrative
€6.5
FV
58.5% overvalued intrinsic discount
7.09%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Metrovacesa S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Metrovacesa
Historical stock prices
Current Share Price€10.30
52 Week High€12.75
52 Week Low€8.45
Beta0.80
1 Month Change-0.48%
3 Month Change-1.44%
1 Year Change20.47%
3 Year Change72.82%
5 Year Change108.29%
Change since IPO-35.63%

Recent News & Updates

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Oct 02
Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Jul 25
Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Recent updates

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Oct 02
Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Jul 25
Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

May 04
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Apr 12
Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest

Feb 26
Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest
User avatar

Will Leverage Undersupplied Spanish Housing Market For Future Opportunities

High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.

Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

Feb 07
Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued

Dec 13
An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Sep 12
Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

Aug 01
We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Jul 17
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

May 28
A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

May 01
We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Mar 27
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Feb 12
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Nov 05
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

Jul 05
These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

May 21
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Apr 19
Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Dec 02
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

Sep 23
Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

May 19
Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Mar 05
Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Feb 16
Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Oct 05
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Jul 02
Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Is Metrovacesa (BME:MVC) Using Too Much Debt?

May 06
Is Metrovacesa (BME:MVC) Using Too Much Debt?

Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Apr 06
Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Mar 15
Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

Feb 16
Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

When Should You Buy Metrovacesa S.A. (BME:MVC)?

Jan 26
When Should You Buy Metrovacesa S.A. (BME:MVC)?

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Jan 05
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Dec 14
If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Shareholder Returns

MVCES Real EstateES Market
7D0%0.2%-0.6%
1Y20.5%3.6%22.7%

Return vs Industry: MVC exceeded the Spanish Real Estate industry which returned 3.6% over the past year.

Return vs Market: MVC underperformed the Spanish Market which returned 23.4% over the past year.

Price Volatility

Is MVC's price volatile compared to industry and market?
MVC volatility
MVC Average Weekly Movement2.5%
Real Estate Industry Average Movement2.5%
Market Average Movement3.0%
10% most volatile stocks in ES Market6.4%
10% least volatile stocks in ES Market0.6%

Stable Share Price: MVC has not had significant price volatility in the past 3 months compared to the Spanish market.

Volatility Over Time: MVC's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1918215Jorge de Leza Eguigurenwww.metrovacesa.com

Metrovacesa S.A. operates as a real estate development company in Spain. It develops and sells residential and commercial premises, as well as sells land. The company was founded in 1918 and is based in Madrid, Spain.

Metrovacesa S.A. Fundamentals Summary

How do Metrovacesa's earnings and revenue compare to its market cap?
MVC fundamental statistics
Market cap€1.56b
Earnings (TTM)-€3.44m
Revenue (TTM)€555.25m
2.8x
P/S Ratio
-454.4x
P/E Ratio

Is MVC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MVC income statement (TTM)
Revenue€555.25m
Cost of Revenue€447.94m
Gross Profit€107.31m
Other Expenses€110.75m
Earnings-€3.44m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.023
Gross Margin19.33%
Net Profit Margin-0.62%
Debt/Equity Ratio28.8%

How did MVC perform over the long term?

See historical performance and comparison

Dividends

7.7%
Current Dividend Yield
n/a
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/15 01:34
End of Day Share Price 2025/10/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Metrovacesa S.A. is covered by 19 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Filipe LeiteBanco BPI, S.A.
null nullBanco de Sabadell. S.A.
Mariano Miguel HidalgoBanco Santander